A Study of Mitoxantrone Hydrochloride Liposome Infusion

Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas

NCT02597153 ·Status: TERMINATED ·Phase: PHASE2

R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

NCT06594640 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.

NCT05990985 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)

NCT07082686 ·Status: RECRUITING ·Phase: PHASE2

A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL

NCT05658562 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT

NCT05493800 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma

NCT00141700 ·Status: TERMINATED ·Phase: PHASE2

A Single-arm, Multicenter, Prospective Clinical Study of Mitoxantrone Liposome Combined With Chidamide and Azacitidine in the Treatment of Relapsed and Refractory Peripheral T-cell Lymphoma

NCT05495100 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012

NCT06565689 ·Status: RECRUITING ·Phase: PHASE1

PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy

NCT02805218 ·Status: COMPLETED ·Phase: PHASE4

Molecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement

NCT06594432 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices

NCT02856646 ·Status: COMPLETED

A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma

NCT01649856 ·Status: COMPLETED ·Phase: PHASE3

R-CMOP in Patients With Primary Diffuse Large B-cell Lymphoma

NCT05777369 ·Status: UNKNOWN ·Phase: NA

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

NCT00290667 ·Status: COMPLETED ·Phase: PHASE2

A Study of C-CAR039 Treatment in Subjects With r/r NHL Subjects Non-Hodgkin's Lymphoma

NCT04693676 ·Status: UNKNOWN ·Phase: PHASE1

Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00244985 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

NCT06970496 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma

NCT07187960 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL

NCT05557903 ·Status: UNKNOWN ·Phase: PHASE1

A Registry Study in Lymphoma Patients Treated With Liposomal Doxorubicin

NCT04069845 ·Status: UNKNOWN

Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma

NCT00425555 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of R/R AITL

NCT06224842 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells

NCT06026995 ·Status: UNKNOWN ·Phase: PHASE4

A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma

NCT05506410 ·Status: RECRUITING